A bacterium could revolutionize the treatment of type 2 diabetes. Type 2 diabetes is the most common (90% of diabetes), the one that is favored by overweight, obesity and that is progressing strongly in the world. More than three million people could be affected by this medical advance. This study will be presented at the congress of the Société francophone du diabète, March 28-31 in Lille.
Conclusive observations on mice
According to the researchers, there is a relationship between the composition of our intestinal microbiota, ie microorganisms that live in our digestive tract, and whether or not diabetes occurs. The presence in numbers of the bacterium, Akkermansia muciniphila, in our intestinal flora, would reduce the risk of type 2 diabetes.
Everything started from an astonishing observation. Researchers were studying the bacteria found in the digestive tract of mice. They realized that this bacterium, Akkermansia muciniphila, was more or less numerous depending on whether the rodent was suffering from diabetes or not. Researchers from Louvin, Belgium, have dug this track. They looked at what was happening if they gave this bacteria to a mouse. As a result, the risk of developing diabetes decreased in these mice.
Patients soon treated with bacteria?
Professor Samy Hadjadj, a diabetologist at the University Hospital of Poitiers, said that "we are not far from the first work that will show whether this bacteria can have a beneficial effect" to reduce diabetes in humans. It is impossible at this time to give a precise deadline, but one can imagine that within a few years it may be enough to take a pinch of this bacterium to reduce its risk of having type 2 diabetes.